William B Cherry, MD | |
7117 Brockton Ave, Riverside, CA 92506-2615 | |
(951) 782-3681 | |
(951) 784-3273 |
Full Name | William B Cherry |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 21 Years |
Location | 7117 Brockton Ave, Riverside, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366429730 | NPI | - | NPPES |
ZZZ31887Z | Other | CA | SITE LOCATION |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 46692 (Minnesota) | Secondary |
207K00000X | Allergy & Immunology | A104582 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Riverside Medical Clinic Inc | 2961492327 | 149 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
› Verified 9 days ago
Entity Name | Riverside Medical Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720183403 PECOS PAC ID: 2961492327 Enrollment ID: O20040517000880 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
William B Cherry, MD 3660 Arlington Ave, Riverside, CA 92506-3912 Ph: (951) 782-3681 | William B Cherry, MD 7117 Brockton Ave, Riverside, CA 92506-2615 Ph: (951) 782-3681 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
› Verified 9 days ago
Dr. Asif Imam, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10683 Magnolia Ave Ste B, Riverside, CA 92505 Phone: 951-351-4026 Fax: 951-351-9982 | |
Thuy Lien Dang Lai, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Dr. Shams Iqbal, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 3600 Lime St, Suite 516, Riverside, CA 92501 Phone: 951-367-1060 Fax: 951-686-5282 | |
Purvee S Shah, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 916-784-4050 | |
Dr. Kristiarsi Rudito, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-5569 |